🎤👨⚕️📊ICOTROKINRA FOR HIGH-IMPACT SITES: In this edition of Practical Dermatology's Skin Minute, Richard B. Warren, MD, PhD, Professor of Dermatology at the University of Manchester, talks about the importance of new 2-year phase 3 clinical data for icotrokinra in adults and pediatric patients 12 years of age and older with difficult-to-treat plaque psoriasis affecting sensitive, highly visible areas of the body.
👀 Watch here ➡️ ow.ly/5TyM5106WZx#psoriasis#icotrokinra#pediatrics#dermatology#pediatricdermatology
🔬 MORPHEA AND CANCER RISK: New research in JAMA Dermatology links both morphea and systemic sclerosis to increased cancer incidence, with important differences in malignancy patterns that may inform clinical vigilance. 🩺
Read more ➡️ ow.ly/zEvb5106Jpr#Dermatology#Morphea#SystemicSclerosis#CancerRisk
New Phase III data from Novartis' RemIND program show sustained responses to Rhapsido (remibrutinib) through Week 52 in patients with chronic inducible urticaria ➡️ ow.ly/OZn15106E4B
🌍🔬📊 AIR POLLUTION AND PEDIATRIC AD: A recent systematic review and meta-analysis published in JAMA Pediatrics examined 52 observational studies and found associations between ambient air pollution and increased atopic dermatitis prevalence and outpatient visits in children ➡️ ow.ly/rkF25105w0A#AtopicDermatitis#PediatricDermatology#AirPollution#DermatologyResearch
🩺⏰👨⚕️SKIN MINUTE: In this edition of Practical Dermatology's Skin Minute,
Practical Dermatology Editorial Board member Raj Chovatiya, MD, PhD, MSCI, FAAD, summarizes the new data presented at the European Academy of Dermatology and Venereology Congress 2026 on the multispecific antibody galvokimig for the treatment of atopic dermatitis.
Watch here ➡️ ow.ly/VwwZ5104STY
💇♀️🩺 A COMPREHENSIVE APPROACH TO HAIR LOSS RESTORATION: In this edition of Practical Dermatology's Skin Minute, Dr. Jeanine Downie, a board-certified cosmetic dermatologist, shares some of her insights and expertise from her presentation at the recent 2026 Skin of Color Update meeting in New York City, regarding her multi-modal approach to treating hair loss across all skin types and hair textures, including nutraceuticals, in-office laser therapy, topical serums, oral minoxidil, and the lifestyle modifications that support optimal regrowth outcomes.
Watch here ➡️ ow.ly/xMHt5103ANC
🔬📊🤖NEW: A recent study of patients with rosacea found metabolic syndrome in 21.5% of participants, with significantly higher CRP levels and disease severity scores among affected patients. Researchers used a machine-learning model that achieved an AUC of 0.734 and identified CRP, total cholesterol, ALT, and HbA1c as leading predictors.
Read more ➡️ ow.ly/jbxZ5102Wlo#Dermatology#Rosacea#MetabolicSyndrome#MachineLearning#DermatologyResearch
🔬 NEW VITILIGO CONSENSUS DOCUMENT: A new international e-Delphi consensus involving 22 experts across 14 countries offers guidance ➡️ ow.ly/kyIe5102Ouu